Role of periovulatory luteinizing hormone concentrations during assisted reproductive technology cycles stimulated exclusively with recombinant follicle-stimulating hormone

Fertil Steril. 2001 Mar;75(3):519-24. doi: 10.1016/s0015-0282(00)01745-3.

Abstract

Objective: To study the effect of endogenous luteinizing hormone (LH) concentration on fertilization, pregnancy, and early pregnancy loss rates.

Design: Retrospective cohort study.

Setting: Tertiary-care university center.

Patient(s): One hundred sixty-six normogonadotropic patients undergoing IVF.

Intervention(s): Luteal phase pituitary down-regulation and recombinant FSH (Gonal-F) were used for ovarian stimulation. The mean of 4-5 serum LH concentrations, from stimulation days 5-12, was computed for analysis.

Main outcome measure(s): Fertilization, pregnancy, and early pregnancy loss rates according to periovulatory levels of LH.

Result(s): Data were analyzed by stratifying patients according to a mean periovulatory LH value of 3 mIU/mL. After controlling for confounding variables with logistic regression, results showed that the fertilization rate was significantly lower in patients with a periovulatory LH <3 mIU/mL versus > or = 3 mIU/mL (52% and 58%, respectively; P=.03). Pregnancy rates and spontaneous abortion rates were similar in both groups. There were seven biochemical pregnancies, all in patients with an LH <3 mIU/mL (P=.07).

Conclusion(s): Low endogenous LH concentrations (<3 mIU/mL) in the late follicular phase of an IVF cycle are associated with significantly lower fertilization rates and a trend toward higher biochemical pregnancy rates. It may be of clinical benefit, when exclusively using r-hFSH in ART cycles, to add LH in the late follicular phase or to further reduce the dose of GnRH agonist.

MeSH terms

  • Abortion, Spontaneous / epidemiology
  • Adult
  • Chorionic Gonadotropin / administration & dosage
  • Cohort Studies
  • Embryo Transfer
  • Estradiol / blood
  • Female
  • Fertilization in Vitro*
  • Follicle Stimulating Hormone / administration & dosage
  • Follicle Stimulating Hormone / therapeutic use
  • Follicle Stimulating Hormone, Human
  • Follicular Phase
  • Humans
  • Logistic Models
  • Luteinizing Hormone / blood*
  • Ovulation Induction
  • Ovulation*
  • Pregnancy
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / therapeutic use
  • Retrospective Studies
  • Sperm Injections, Intracytoplasmic

Substances

  • Chorionic Gonadotropin
  • Follicle Stimulating Hormone, Human
  • Recombinant Proteins
  • Estradiol
  • Luteinizing Hormone
  • Follicle Stimulating Hormone